Zobrazeno 1 - 10
of 10
pro vyhledávání: '"José María Raya"'
Autor:
A. Allende-Riera, D. Cabello-García, Sunil Lakhwani, C. Cárdenas-Negro, Miguel T. Hernández-García, José María Raya
Publikováno v:
Medicina Clínica (English Edition). 150:104-106
Background and objectives To compare bone marrow biopsy (BMB) and PET/CT in detecting bone marrow involvement in Hodgkin's lymphoma. Material and methods Retrospective analysis of 65 patients with both tests in the initial staging or in relapse with
Autor:
Sonia García Hernández, Hugo Álvarez-Argüelles Cabrera, Silvia Martín Batista, Ángel Nazco Deroy, José María Raya Sánchez
Publikováno v:
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia. 52(2)
We present a case of a nasal rhabdomyosarcoma (RMS) in a 27-year-old male with epistaxis and nasal obstruction due to a mass, which was subjected to prophylactic tumor embolization. However, histopathological study on the nasal biopsy was impossible
Autor:
Marta Romera, Taida Martín-Santos, José María Raya, Francisco José Ortuño, Maria del Puig Cozar, Jose Contreras, José Luis Navarro, Carolina Villegas, Jose Javier Sanchez-Blanco, Hermogenes Fernandez-Muñoz, Raquel Sánchez-Vañó, Leonor Senent, Laura Frutos, Begoña Muiña, Juan Carlos Herrera, Andres Jerez, Maria Teresa Orero, Tzu-Hua Chen-Liang, Jon Uña, Aima Lancharro, Marta Fernández-González, Elena Pérez-Ceballos, Carolina Igua, Maria Jose Remigia
Publikováno v:
American Journal of Hematology. 90:686-690
Bone marrow infiltration (BMI), categorized as an extra-nodal site, affects stage and is associated with poor prognosis in newly diagnosed lymphoma patients. We have evaluated the accuracy of PET/CT and bone marrow biopsy (BMB) to assess BMI in 372 l
Autor:
Sunil Lakhwani, José María Raya Sánchez, Maribel Díaz-Gómez, Miguel T. Hernandez, Deborah Cabrera-Brito, Patricia Machado-Machado, Marta Fernández-González, Pablo Lorenzo-Barreto
Publikováno v:
Blood. 132:5595-5595
Background. During the last years survival of myeloma patients has improve due mainly to the introduction of new drugs. Despite this, there are patients who die early: before two years from diagnosis. There are few data published of this group of pat
Autor:
Jesús M. Hernández, Blanca Xicoy, Joan Bargay, Elisa Luño, Benet Nomdedeu, Carme Pedro, Guillermo Sanz, Carmen Sanzo, José María Raya, Rosa Collado, Felix Carbonell, Miguel A. Gallart, Consuelo del Cañizo, Silvia Saumell, Leonor Arenillas, Francesc Solé, José Cervera, Luis Belloch, Lourdes Florensa, Teresa Vallespi
Publikováno v:
British Journal of Haematology. 159:311-321
Trisomy 8 is the most common chromosomal gain in myelodysplastic syndromes (MDS), however, little is known about the features of MDS with isolated trisomy 8 and the influence of additional cytogenetic aberrations. We determined the characteristics an
Autor:
José Tomás Navarro, Marina Díaz-Beva, Taida Martín-Santos, José María Raya, Esperanza Tuset, Esperanza Such, Alfredo Bermejo, Sonia González-de-Villambrosia, Ana Batlle, Teresa Vallespi, Fuensanta Millá, Maria Luz Perez-Sirvent, Margarita Ortega, Lourdes Florensa, María Rozman, Valeria Peri, Elisa Luño, Esther Alonso, Alicia Domingo, Marisa Martín-Ramos, Francesc Solé, Carmen Sanzo
Publikováno v:
Hematology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Objectives: To compare, from a biological and clinical perspective, a significant group of patients with AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) with another group of AML carrying different abnormalities of 3q at q21 or q26, the latter named a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51614dfde1fc03d7313a9378c79a0bc
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2042
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2042
Autor:
Queipo de Llano Mp, Dolors Colomer, Andreu Llorente, Jordi Sierra, Luz Muñoz, José María Raya Sánchez, Josep F. Nomdedeu, Josep-Maria Ribera, Salut Brunet, Juan Berlanga, C. Fernández, JP Torres, Ramon Guardia, Neus Villamor
Publikováno v:
Leukemia. 17:76-82
The MLL gene, located at 11q23 band, is frequently disrupted by different chromosomal rearrangements that occur in a variety of hematological malignancies. MLL rearrangements are associated with distinct clinical features and a poor prognosis. The ai
Autor:
Javier Menárguez, José María Raya, Carlos Besses, María Rozman, Santiago Montes-Moreno, Reyes Calzada, Juan F. García, Empar Mayordomo-Aranda, Agustín Acevedo, Antonio Ferrández, Mar Garcia, Máximo Fraga
Publikováno v:
JOURNAL OF CLINICAL PATHOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Aims The diagnosis of primary myelofibrosis (PMF) strongly relies on the bone marrow biopsy findings, but a report model has not been standardised. Our aim was to establish general recommendations for bone marrow evaluation and standardised reporting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f38a785915e601afa6103355dae6adc4
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8675
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8675
Autor:
Carmen Burgaleta, Joaquin Martinez-Lopez, Pilar Herrera, Inmaculada Rapado, Joan Ballesteros, Eva Barragán, José María Raya Sánchez, Santiago Barrio, David R. Martinez, Esther Onecha, Pau Montesinos, José Luis Rojas, Rosa Ayala
Publikováno v:
Blood. 126:1376-1376
Background. The AML is a heterogeneous disease with a high variety of subtypes stratified by cytogenetic and molecular markers. To date, the major prognosis criteria is cytogenetic, but 40-50% of de novo AML patients have normal karyotype; AML treatm
Autor:
Helena Pomares, Montserrat Arnan, Julia Montoro, Juan D. Rodríguez-Gambarte, Carmen Sanzo, Eduardo Ríos, Andres Jerez, Teresa Giménez, Elisa Luño, Carme Pedro, Raquel de Paz, Blanca Espinet, Judith Sánchez-Castro, Francesc Solé, Beatriz Arrizabalaga, Silvia Saumell, David Valcárcel, María Rodríguez-Rivera, José María Raya, Lourdes Florensa, Leonor Arenillas, Ana Maria Barral de Martinez
Publikováno v:
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0129375 (2015)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0129375 (2015)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarif